GVS-111 prevents oxidative damage and apoptosis in normal and Down’s syndrome human cortical neurons

@article{Pelsman2003GVS111PO,
  title={GVS-111 prevents oxidative damage and apoptosis in normal and Down’s syndrome human cortical neurons},
  author={Alejandra Pelsman and Carlos Hoyo-Vadillo and Tatiana A Gudasheva and Sergei B Seredenin and Jorge A. Busciglio},
  journal={International Journal of Developmental Neuroscience},
  year={2003},
  volume={21},
  pages={117-124}
}
The neuroprotective activity of a novel N-acylprolyl-containing dipeptide analog of the nootropic 2-oxo-1-pyrrolidine acetamide (Piracetam) designated as GVS-111 (DVD-111/Noopept) was tested in two in vitro models of neuronal degeneration mediated by oxidative stress: normal human cortical neurons treated with H(2)O(2), and Down's syndrome (DS) cortical neurons. Incubation of normal cortical neurons with 50 microM H(2)O(2) for 1h resulted in morphological and structural changes consistent with… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 9 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Neurometabolic effects of prolyl-containing cognition enhancer GVS-111 suggests its effectiveness in Alzheimer disease

R. Ostrovskaya, T. Gudasheva, N. Andreeva, I. Victorov
Neuroscience Lett. (Suppl.) • 1998
View 3 Excerpts
Highly Influenced

[Anti-inflammatory properties of noopept (dipeptide nootropic agent GVS-111)].

Eksperimental'naia i klinicheskaia farmakologiia • 2002
View 1 Excerpt

Behavioral and electrophysiological analysis of the cholino-positive effect of the nootropic acyl-prolyl containing dipeptide, GVS-111

R. U. Ostrovskaya, T. Mirsoev, +5 authors E. Barkova
Exp. Clin. Pharmacol. (Russia) • 2001
View 2 Excerpts

Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology • 2001

Similar Papers

Loading similar papers…